Devonian Health GroupDVHGF 49 Days Payable is 417.12 as of Jan. 2026, which is 219% above its 10-year median of 130.68. GuruFocus rates DVHGF with a GF Score™ of 49/100 and a GF Value™ of $3.02 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 702 Biotechnology companies, Devonian Health Group ranks better than 66.52% on this metric.
Devonian Health Group Days Payable Historical Data
* Premium members only.
The historical data trend for Devonian Health Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DVHGF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Devonian Health Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Devonian Health Group Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Devonian Health Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Devonian Health Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Devonian Health Group's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Devonian Health Group (DVHGF) has a Days Payable of 417.12 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Devonian Health Group and its competitors. This is 219% above median its historical median of 130.68. Over the past decade, Devonian Health Group's Days Payable has ranged from 68.98 to 239.16. According to the industry distribution chart, Devonian Health Group ranks #235 out of 702 companies in the Biotechnology industry, placing it in the top 33.5%.
Is Devonian Health Group's Days Payable too high?
Devonian Health Group's current Days Payable of 417.12 is 219% above median its 10-year median of 130.68. Over the past 10 years, this metric has ranged from a low of 68.98 to a high of 239.16. The Biotechnology industry median Days Payable is 113.56. Devonian Health Group's value of 417.12 is 267.3% above this industry median. Based on the distribution chart, Devonian Health Group ranks #235 out of 702 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Devonian Health Group has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Devonian Health Group's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Devonian Health Group ranks #235 out of 702 companies for Days Payable. This puts Devonian Health Group in the upper half of its industry. The industry median Days Payable is 113.56. Devonian Health Group's value of 417.12 is 267.3% above this benchmark. Historically, Devonian Health Group's own Days Payable has ranged from 68.98 to 239.16 over the past decade. While the company's 10-year median is 130.68 vs. the industry median of 113.56, Devonian Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Devonian Health Group's current Days Payable of 417.12 is 267.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Devonian Health Group and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Devonian Health Group's current Days Payable is 417.12, which is 219% above median its own 10-year median of 130.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devonian Health Group stock overvalued right now?
Based on GuruFocus' analysis, Devonian Health Group (DVHGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.02, compared to a current price of $7.00 — trading 131.8% above its estimated fair value. The current Days Payable is 417.12, which is 219% above median its 10-year median of 130.68 and 267.3% above the Biotechnology industry median of 113.56. Devonian Health Group's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Devonian Health Group (DVHGF), the current Days Payable is 417.12 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Devonian Health Group (DVHGF) Overvalued in 2026?
Based on GuruFocus' analysis, Devonian Health Group stock appears to be overvalued.
The current stock price of $7.00 is trading 131.8% above its estimated GF Value™ of $3.02.
GuruFocus considers Devonian Health Group to be Significantly Overvalued.
Key valuation signals for DVHGF:
Days Payable: 417.12 (219% above median its 10-year median of 130.68)
GF Value™: $3.02 vs. price of $7.00 (131.8% above fair value)
Industry Position: 267.3% above the Biotechnology median (#235 of 702)
No single metric tells the full story. See the DVHGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
49GF Score
Get the complete analysis for DVHGF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DVHGF has been successfully added to your 
